JacquelineJonklaasMD
Endocrinology • Washington, DCAdrenal Disease, Diabetes, Pituitary Disorders & Neuroendocrinology, Thyroid
Professor, Medicine, Georgetown University School of Medicine
Dr. Jonklaas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4000 Reservoir Rd Nw
Bldg D Suite 230
Washington, DC 20007Phone+1 202-687-2818
Education & Training
MedStar Health/Georgetown University HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1996 - 1998- MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 1993 - 1996
Georgetown University School of MedicineClass of 1993
Certifications & Licensure
DC State Medical License 1997 - 2024
MD State Medical License 2000 - 2002- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
- Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy Start of enrollment: 2004 Dec 01
- The Effect of Coffee on the Absorption of Thyroid Hormone in Patients With Thyroid Carcinoma Start of enrollment: 2012 Sep 01
Publications & Presentations
PubMed
- Radioactive Iodine Treatment for Thyroid Cancer Complicated by Lacrimal Sac Retention of Iodine.Annu Suresh, Giuseppe Esposito, Bruce Davidson, Pavle Doroslovački, Jacqueline Jonklaas
JCEM Case Reports. 2025-01-01 - Application of Human Plasma Targeted Lipidomics and Analysis of Toxic Elements to Capture the Metabolic Complexities of Hypothyroidism.Anna Błażewicz, Michał Kiełbus, Katarzyna Skórzyńska-Dziduszko, Andreas M Grabrucker, Jacqueline Jonklaas
Molecules. 2024-10-31 - TSH Reference Intervals: Their Importance and Complexity.Jacqueline Jonklaas
Thyroid. 2024-08-01
Lectures
- Thyroid Hormone Preparations: If, When, and Why You Should Deviate from LevothyroxineENDO 2019 - New Orleans, LA - 3/23/2019
- ESAP LiveENDO 2019 - New Orleans, LA - 3/24/2019
- Thyroid Hormone Preparations: If, When, and Why You Should Deviate from Levothyroxine (Repeat)ENDO 2019 - New Orleans, LA - 3/23/2019
- Join now to see all
Authored Content
- What Does the Future Hold for T3 and T4 Combination Therapy Studies?November 2019
Press Mentions
Examining T4/T3 Combination Therapy in HypothyroidismNovember 21st, 2024- Preview of the 93rd American Thyroid Association Annual MeetingJuly 1st, 2024
- American Thyroid Association Announces Award RecipientsJuly 12th, 2021
- Join now to see all
Grant Support
- Serum Selenium Levels And Thyroid Cancer DevelopmentNational Center For Research Resources2008–2009
- Identification Of Leukocyte Genes That Are Regulated By Thyroid HormoneNational Center For Research Resources2008
- Comparison Of Thyroid Hormone Levels Found With Normal Thyroid Functioning, CNational Center For Research Resources2008
- Comparison Of Cortison Levels During An ACTH Stimulation Test Using Tandem MassNational Center For Research Resources2007
- Identification Of Leukocyte Genes That Are Regulated By Thyroid HormoneNational Center For Research Resources2006–2007
- Comparison Of Thyroid Hormone Levels Found With Normal Thyroid Functioning, CNational Center For Research Resources2006–2007
- Mentored Patient-Oriented Research Career Development AwardNational Center For Research Resources2005–2006
- Levothyroxine: Triiodothyronine Combination Therapy For HypothyroidismNational Center For Research Resources2005
- Thyroid Hormone Levels With Normal Thyroid To Level After ThyroidectomyNational Center For Research Resources2004
- Levothyroxine: Triiodothyronine Combination TherapyNational Center For Research Resources2002–2004
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
